Welcome to eDrug Plus! :wave:
|
|
1
|
300
|
August 26, 2023
|
Lexique de la pharmacie clinique 2025
|
|
0
|
17
|
February 12, 2025
|
L’OMéDIT Centre – Val de Loire vous propose son guide des antidotes
|
|
0
|
5
|
February 12, 2025
|
Opioïdes : recommandations en cas de changement de molécule ou de voie d'administration
|
|
0
|
13
|
February 12, 2025
|
La Pilule d'Or Prescrire 2024
|
|
0
|
39
|
February 10, 2025
|
Identifier les faux vaccins Covid-19 en analysant les étiquettes des flacons et les liquides vaccinaux
|
|
0
|
12
|
February 10, 2025
|
Pubic Pharma: What is it and why it's important? Государственная фармацевтика: Почему это важно?
|
|
0
|
33
|
February 9, 2025
|
Welcome to new E-Lek in 2025!
|
|
0
|
16
|
January 15, 2025
|
[e-lek] Thank you for your support to E-DRUG!
|
|
2
|
42
|
January 14, 2025
|
Cochrane Russia Podcast: Niacin for people with or without established cardiovascular disease
|
|
0
|
13
|
January 14, 2025
|
L’industrie pharma contrôle les prescriptions médicales… patients, experts, médecins, politiques, agences sont les suiveurs
|
|
0
|
32
|
January 7, 2025
|
Quand une firme pharmaceutique retarde l’apparition de génériques (Europe)
|
|
0
|
19
|
January 7, 2025
|
Public Alert No. 050/2024 -Alert on the Recall of Apo-Amitriptyline 10mg and 25mg Manufactured by Pharma Forte Singapore Pte Ltd. - NAFDAC
|
|
0
|
49
|
January 4, 2025
|
Rappel - i+solutions' bourse annuelle
|
|
0
|
6
|
December 22, 2024
|
Reminder - i+solutions yearly scholarship
|
|
0
|
5
|
December 22, 2024
|
ITM course on Pharmaceutical Policies in Health Systems: 26/5-13/6/2025
|
|
0
|
30
|
December 17, 2024
|
Le Sénégal et le Rwanda atteignent le niveau de maturité 3 de l'OMS en matière de réglementation des médicaments
|
|
0
|
29
|
December 9, 2024
|
Beyond Access to Insulin: A Story of Two Approaches to Care
|
|
0
|
33
|
December 6, 2024
|
I+solutions - bourse annuelle
|
|
0
|
23
|
December 3, 2024
|
i+solutions - annual scholarship
|
|
0
|
13
|
December 3, 2024
|
Lutte contre le paludisme : une nouvelle résistance aux traitements standards observée chez les enfants
|
|
1
|
18
|
November 26, 2024
|
Patent status for essential medicines in LMICs
|
|
0
|
25
|
November 25, 2024
|
Risdiplam - an essential medicine for SMA
|
|
0
|
8
|
November 25, 2024
|
WHO: Urgent action needed as global diabetes cases increase four-fold over past decades
|
|
0
|
4
|
November 25, 2024
|
Low- And Middle-Income Countries Experienced Delays Accessing New Essential Medicines, 1982-2024
|
|
0
|
9
|
November 25, 2024
|
Exploring the feasibility of sharing information on medicine prices across countries OECD Health Working Papers No. 171
|
|
0
|
22
|
November 25, 2024
|
Projet d'accès au céfidérocol
|
|
0
|
15
|
November 20, 2024
|
Access to diabetes treatment and care: new film launches Friday 29 November
|
|
0
|
18
|
November 23, 2024
|
Webinar: Framework Agreements in Humanitarian Settings Dec. 10, 2024 at 9 AM ET/14:00 UTC
|
|
0
|
5
|
November 23, 2024
|
Les enfants, grands oubliés de la recherche contre les maladies tropicales négligées
|
|
0
|
13
|
November 22, 2024
|